MedTrace Logo

Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management

NCT06959810 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2026-03-12

No results posted yet for this study

Summary

Treatment for cancers of the pharyngolarynx is mutilating, with major consequences for patients' lives in terms of physical and functional after-effects. The psycho-social consequences are also significant, notably the metamorphosis of identity linked to the disease and its treatment, which alters the patient's self-image.

Initial feedback from patients who have been able to benefit from adapted oncoesthetics (OEA) is overwhelmingly positive.

This study will assess the feasibility of oncoesthetics and describe any obstacles.

Conditions

  • Oncology
  • Aerodigestive Tract Cancer
  • Suportive Care

Interventions

OTHER

Adapted Onco-Esthetics sessions

Patient will received three sessions of Adapted Onco-Esthetics

Sponsors & Collaborators

  • Fondation de France

    collaborator OTHER

  • GIRCI NO

    collaborator UNKNOWN

  • Centre Francois Baclesse

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-24
Primary Completion
2027-09-15
Completion
2028-09-15

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06959810 on ClinicalTrials.gov